The Alzheimer's Disease Amyloid Precursor Protein Modulates Copper-Induced Toxicity and Oxidative Stress in Primary Neuronal Cultures
Open Access
- 1 November 1999
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 19 (21), 9170-9179
- https://doi.org/10.1523/jneurosci.19-21-09170.1999
Abstract
The amyloid precursor protein (APP) of Alzheimer's disease can reduce copper (II) to copper (I) in a cell-free system potentially leading to increased oxidative stress in neurons. We used neuronal cultures derived from APP knock-out (APP−/−) and wild-type (WT) mice to examine the role of APP in copper neurotoxicity. WT cortical, cerebellar, and hippocampal neurons were significantly more susceptible than their respective APP−/−neurons to toxicity induced by physiological concentrations of copper but not by zinc or iron. There was no difference in copper toxicity between APLP2−/−and WT neurons, demonstrating specificity for APP-associated copper toxicity. Copper uptake was the same in WT and APP−/−neurons, suggesting APP may interact with copper to induce a localized increase in oxidative stress through copper (I) production. This was supported by significantly higher levels of copper-induced lipid peroxidation in WT neurons. Treatment of neuronal cultures with a peptide corresponding to the human APP copper-binding domain (APP142–166) potentiated copper but not iron or zinc toxicity. Incubation of APP142–166 with low-density lipoprotein (LDL) and copper resulted in significantly increased lipid peroxidation compared to copper and LDL alone. Substitution of the copper coordinating histidine residues with asparagines (APP142–166H147N, H149N, H151N) abrogated the toxic effects. A peptide corresponding to the zinc-binding domain (APP181–208) failed to induce copper or zinc toxicity in neuronal cultures. These data support a role for the APP copper-binding domain in APP-mediated copper (I) generation and toxicity in primary neurons, a process that has important implications for Alzheimer's disease and other neurodegenerative disorders.Keywords
This publication has 61 references indexed in Scilit:
- Collection and normal levels of the amyloid precursor protein in plasmaAnnals of Neurology, 1997
- The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)Science, 1996
- β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityCell, 1995
- Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP)FEBS Letters, 1994
- The βA4 amyloid precursor protein binding to copperFEBS Letters, 1994
- The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowthNeuron, 1992
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitabilityNeuroscience Letters, 1989
- An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's diseaseNeurobiology of Aging, 1986
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinBiochemical and Biophysical Research Communications, 1984